4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-22-007754
Director bought 7,000 shares at $1.40 ($9,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Mulroy Michael H. Director | 2022-03-24 | Purchase | +7,000 | $1.40 | $9,800 | 258,555 | D |
| Open-market purchases · 7,000 sh · avg $1.40 · $9,800 | |||||||
Loading xslF345X03/ownership.xml…